Posterior Pituitary Flashcards
Posterior Pituitary Peptide structure
- Both are 9AA (differ only at 2AA)
ADH: Phe, Arg// Oxy: Ile, Leu
- Internal disulfide bond
- Possible progenitor gene: vasotocin (expressed in pineal gland)
Function & physiological advantages of modifications to posterior pituitary peptide hormones
- amidated glycine at carboxy end protects peptide from degradation
- amino terminal end is protected by a disulfide bond
- Prolongs half-life
Vasopressin receptors (3)
- V2: Gαs –> adenylyl cyclase
* distal and collecting tubules - V1a: Gαq –> phospholipase C
* smooth muscle; vasoconstriction - V1b: Gαq –> phospholipase C
* anterior pituitary; +ACTH
Circumventricular organs (6)
- OVLT: organum vasculosum laminae terminalis
SFO: subfornical organ
- Location of cerebral osmoreceptors
- Responds to changes in blood osmolality (less than 1%)
- Windows through the blood brain barrier; sample salt and solute concentrations in blood
- Rich in osmoreceptors
- Send positive signals to magnocellular neurons
Non-osmotic receptor afferents (3)
Baroreceptors (cardiovascular input)
- Mainly inhibitory, negative signals
- As blood pressure increases, secretion of ADH decreases
- Senses changes in volume
Osmotic threshold
280 mOsm/kg
Minimum osmolality in which vasopressin secretion will occur
Regulation of vasopressin secretion
- Linear relationship with osmolality
- Maximal antidiuresis: 5pg/ml plasma ADH
- above this, can no longer concentrate urine further
- Signals thirst
- Linear relationship with uring osmolality
- Maximal/normal concentrated urine:
800-1000 mOsm/kg
Osmoreceptor-vasopressin-renal reflex (4)
- 1% Increase TBW
- 2% Increase TBW
- 2% Decrease TBW
- Increase in plasma osmolality
- 1% increase TBW: 1/2 decrease plasma ADH & 1/2 urine osmolality
- 2% increase TBW- Maximal ADH suppression:
low plasma ADH & low urine osmolality (max dilute)
- 2% decrease TBW- Maximal concentration of urine:
2x increase plasma ADH & high urine osmolality
- Increase Uos: slight increase in ADH & urine osmolality
1/3 increase in ADh = 1/2 amount of urine
Antiduresis & Thirst
- Above maximal diuresis, additional ADH secreted, but no increase in urine concentration
- Avoid dehydration by stimulating osmoreceptors (5-10 mOsm/kg) FOR THIRST
- Cold-sensitive Oropharyngeal receptors inhibit ADH secretion
Baroreceptor activation
- Sources: left atrium, caroic sinus, aortic arch
- Activated when hypervolemic and hypertensive:
INHIBITS ADH secretion
- At a given BP, relationship remains linear
- As BP rises, osmotic threshold increases = more changes in plasma osm to secrete ADH
- Hypovolemic and hypotensive - steep linear
Vasopressin action
- ADH binds to V2 receptors
- Activate adenylate cyclase: ATP –> cAMP
- Protein kinase A
- Fusion of aquaporins (AQP2) to apical membrane
Facilitated diffusion
Excretion of sodium in kidney
- Low blood volume –> increase renin
- Angiotensinogen –> angiotensin I
- ACE converts to angiotensin II
- increase ALDOSTERONE
- Na reabsorption; increase serum tonicity K excretion
- Can stimulate ADH secretion
- Angiotensin II stimulates vasoconstriction of smooth muscle
Atrial Natriuretic protein (ANP) (4)
- Activated by stress receptors in the heart
- Negative feedback on Renin secretion from kidney
- Causes increased GFR to ultimately decrease ADH secretion and decrease blood volume
- Vasorelaxation on vascular smooth muscle to decrease blood pressure
Central diabetes insipidus
&
Etiologies (4)
- Mutation in secreting biologically active ADH
- gene mutation
- improper processing - Exretion of large volume of dilute urine that can’t be reduced by fluid intake; kidney can not concentrate urine
Etiologies: hypothalamic/pituitary tumor*(before/after surgery), idiopathic (spontaneous), histiocytosis, trauma*
Nephrogenic diabetes insipidus
(peripheral)
- Dysfunction at the level of the kidney
- mutation in V2 receptor
- mutation in aquaporin 2